**Core Concept:** Phenylketonuria (PKU) is an inborn error of amino acid التمثيل الحيوي, which results from deficiency in the liver enzyme phenylalanine hydroxylase (PAH). PAH catalyzes the conversion of phenylalanine to tyrosine, which is a crucial step in phenylalanine degradation.

**Why the Correct Answer is Right:** Phenylalanine hydroxylase deficiency leads to accumulation of phenylalanine in the body, causing neurological damage and intellectual impairment if not treated. PKU is an autosomal recessive disorder, which means it requires inheritance of two mutated copies of the PAH gene (PAH gene on chromosome 12).

**Why Each Wrong Option is Incorrect:**

A. Tyrosinemia (Type I) is a different inborn error of amino acid التمثيل الحيوي, caused by deficiency in fumarylacetoacetase enzyme, which leads to accumulation of succinylacetone in urine. Tyrosinemia does not involve deficiency of PAH and has different clinical manifestations.

B. Tyrosinemia (Type II) is a different inborn error of amino acid التمثيل الحيوي, caused by deficiency in 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase enzyme involved in cholesterol synthesis, not PAH deficiency.

C. Tyrosinemia (Type III) is caused by deficiency in α-ketoglutarate dehydrogenase enzyme, not PAH deficiency.

D. Tyrosinemia (Type IV) is caused by deficiency in fumarylacetoacetase enzyme, not PAH deficiency.

**Clinical Pearl:** Phenylketonuria (PKU) screening is a routine practice for newborns to detect high phenylalanine levels in blood, enabling early initiation of a low-phenylalanine diet and preventing neurological complications.

**Correct Answer:** D. Tyrosinemia (Type IV) is caused by deficiency in fumarylacetoacetase enzyme, not PAH deficiency. Tyrosinemia (Type IV) is caused by mutations in the FAH gene, encoding fumarylacetoacetase enzyme, which is involved in the degradation of tyrosine. Tyrosinemia (Type IV) results in high blood tyrosine levels, not phenylalanine.

**Core Concept**

The Phenylalanine hydroxylase enzyme converts phenylalanine to tyrosine, a process that is essential for neurotransmitter synthesis and myelin formation. In PKU, phenylalanine accumulates due to PAH deficiency, leading to neurological complications if untreated.

**Why Each Wrong Option is Incorrect**

A) Tyrosinemia (Type I) is caused by mutations in the HMG-CoA reductase gene, leading to high cholesterol levels, not phenylalanine.

B) Tyrosinemia (Type II) is caused by mutations in the AMPD1 gene, resulting in high adenine nucleotide deaminase activity, not phenylalanine.

C) Tyrosinemia (Type III) is caused by mutations in the GART gene, leading to decreased tetrahydro